Intersect ENT competitorsClear all

Intersect ENT's top competitors include Lyra Therapeutics, Regeneron Pharmaceuticals and OptiNose.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Intersect ENT
Intersect ENT
Intersect ENT is an ear, nose, and throat medical technology company.
Lyra Therapeutics
Lyra Therapeutics
Lyra Therapeutics is a therapeutics company focused on the development of integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
OptiNose
OptiNose
OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
Founding Date
Founding Date
2003
Founding Date
2005
Founding Date
1988
Founding Date
2000
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Menlo Park, US HQ
Locations
Watertown, US HQ
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Uxbridge, GB
Bernards, US
Rensselaer, US
Sleepy Hollow, US
see more
Locations
Morrisville, US HQ
Oslo, NO
Swindon, GB
Employees
Employees
4061% increase
Employees
34
Employees
9,12313% increase
Employees
2048% decrease
Valuation ($)
Valuation ($)
892.8 m
Valuation ($)
101.9 m
Valuation ($)
61 b
Valuation ($)
150.3 m
Twitter followers
Twitter followers
978
Twitter followers
58
Twitter followers
30.4 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
13
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
29
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
3.8
Average likes per tweet (last 30 days)
0.7
Average likes per tweet (last 30 days)
8.8
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
84.62%
Percentage of tweets with engagement (last 30 days)
63.64%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
388076
Alexa Website Rank
322672
Alexa Website Rank
183060
Alexa Website Rank
529184
Employee Rating
Employee Rating
2.6
Employee Rating
3.3
Employee Rating
3.9
Employee Rating
3.6

Financial

Revenue (est.)
Revenue (est.)
$80.6m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$8.5b (FY, 2020)
Revenue (est.)
$49.1m (FY, 2020)
Cost of goods
Cost of goods
$30.3m (FY, 2020)
Cost of goods
N/A
Cost of goods
$1.1b (FY, 2020)
Cost of goods
$7.5m (FY, 2020)
Gross profit
Gross profit
$50.2m (FY, 2020)
Gross profit
N/A
Gross profit
$7.4b (FY, 2020)
Gross profit
$41.6m (FY, 2020)
Net income
Net income
($72.3m) (FY, 2020)
Net income
($22.1m) (FY, 2020)
Net income
$3.5b (FY, 2020)
Net income
($99.8m) (FY, 2020)

Operating

Patents (US)
Patents (US)
30 (FY, 2016)
Patents (US)
N/A
Patents (US)
31 (FY, 2020)
Patents (US)
43 (Jun, 2017)
Products
Products
2 (FY, 2016)
Products
N/A
Products
7 (FY, 2020)
Products
N/A
Trademarks
Trademarks
29 (FY, 2016)
Trademarks
N/A
Trademarks
18 (FY, 2020)
Trademarks
N/A
Trademarks (US)
Trademarks (US)
4 (FY, 2016)
Trademarks (US)
N/A
Trademarks (US)
N/A
Trademarks (US)
3 (Jun, 2017)

Funding

Total funding raised
Total funding raised
$ 102.9m
Total funding raised
$ 59.5m
Total funding raised
$ 8.9m
Total funding raised
$ 120.5m
For sources of this data, please see the company profile

View company profiles

Lyra Therapeutics
HQ
Watertown, US
Employees
34

Lyra Therapeutics is a therapeutics company focused on the development of integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases.

View company
Regeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
9,123↑ 13% increase

Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.

View company
OptiNose
HQ
Morrisville, US
Employees
204↓ 8% decrease

OptiNose develops nasal drug delivery technologies and combination drug-device therapies.

View company